Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing

Completed

• Conditions: Overactive Bladder Syndrome

• Registration Number: NCT01819168
• Lead Sponsor: Far Eastern Memorial Hospital

Brief Summary

The aim of this retrospective study is to analyze if nighttime antimuscarincs may be more effective in treating patients with nocturia.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-03
• Study First Submitted: 2013-03-21
• Study First Submitted QC: 2013-03-26
• Study First Posted: 2013-03-27
• Primary Completion: 2015-03
• Status Verified: 2016-02
• Study Completion: 2016-04
• Last Update Submitted: 2016-09-04
• Last Update Posted: 2016-09-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 38

Inclusion Criteria

• patients who underwent tolterodine SR treatment once per day for 12 weeks in Department of Obstetrics & Gynecology in National Taiwan University Hospital and Far Eastern Memorial Hospital

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
bladder diary	3 months	To clarity any difference of reduction in the episodes of nocturia between these two groups.

Secondary Outcome Measures

Name	Time	Method
Frequency and Urgency	3 months	To clarity any difference of reduction in the episodes of urinary frequency and urgency between these two groups.

Trial Locations

Locations (1)

Far Eastern Memorial Hospital; 🇨🇳 Pan-Chiao,, New Taipei, Taiwan